количество зарегистрированных пользователей: 29052 ab.rumedo.ru

Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the CLARICOR randomised, blinded clinical trial

Статья на английском языке.

The CLARICOR trial reported that clarithromycin compared with placebo increased all-cause mortality in patients with stable coronary heart disease. This study investigates the effects of clarithromycin versus placebo during 10 years follow up.

15.05.2019

Отправить ответ

Оставьте первый комментарий!